You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Research on prevention. Research on care delivery systems. Research on health care organization. Health technology assessment
Health care and its financing will not be harmonized within the European Union (EU). Therefore, the differences between the health systems of the member-states in a Single European Market are gaining in relevance. The process of economic integration also effects health. This book integrates economics, law, social, political and health sciences in the analysis of health care issues in the EU. It covers the development of health systems and policy in the community, the markets for pharmaceuticals and for medical devices, EU-trends in hospital financing, issues in the comparison of financing systems, especially in the field of private expenditures, reforms of health care financing in social security systems and national health services in the EU and cross-border health care between EU member-states. The results feature an up-to date overview on the European dimension of health care and its financing. The book is relevant to experts in health care organizations, policy, industry and research.
Human aging is perhaps the most complex and important subject that will be facing science and societies in the next century. Persons seem to be living longer and remaining more active than their parents and grandparents. This is leading to social and demographic shifts that must be accommodated by society. On the other hand it presents perplexing questions about the underlying processes and determinants of healthy aging. This book gives a design for research that will increase our understanding of the factors that influence healthy aging and can lead to improvements in reducing the levels of disability in the population. It's focus is on biobehavioural and psychological factors contributing ...
In recent years there have been tremendous advances in the fields of chemistry, physics and biology which have a direct impact on advances in biomaterials science. Many areas of healthcare depend upon the development of novel biomaterials. This book contains contribution from scientists who have made numerous innovative and exciting advances in the field of biomedical materials. The latest advances in the field are covered including studies of cell interactions with biomaterials. The assessment of the potential applications for the development of new biomaterials, tissue engineering and future medical devices are discussed. It will also provide an opportunity to discuss the latest developments in the field and the vision for the future. The book clearly illustrates how basic and applied research are being combined to produce novel biomaterials.
EUCAMBIS was established under BIOMED I in 1994 as an interdisciplinary consortium aiming to advance our understanding of the molecular and cellular bases of ageing of immunosenescence. The project sought to draw together scientists and clinicians from diverse fields including immunology, molecular biology, cell and tumour biology, geriatrics, endocrinology and transplantation biology in order to investigate the impact of ageing on immune responses. The papers collected in this volume illustrate the diversity of the work carried out by the members of EUCAMBIS during its three-and-a-half year existence. This introductory chapter attempts to summarize the results of some of the EUCAMBIS collaborations, with emphasis on the "workshop" approach which was aimed at analysing the expression of "growth arrest" genes in ageing human T lymphocytes.
As in previous editions, the focus in ESSENTIAL MATHEMATICS with APPLICATIONS remains on the Aufmann Interactive Method (AIM). Students are encouraged to be active participants in the classroom and in their own studies as they work through the How To examples and the paired Examples and You Try It problems. Student engagement is crucial to success. Presenting students with worked examples, and then providing them with the opportunity to immediately solve similar problems, helps them build their confidence and eventually master the concepts. Simplicity is key in the organization of this edition, as in all other editions. All lessons, exercise sets, tests, and supplements are organized around ...
With its roots in the last century and currently exploiting the technology of today, the science of drug metabolism has made significant contributions to our understanding of chemico-biological interactions. This book reviews past successes and failures within the science and attempts to predict new directions. Each of the chapters of this book deals with an aspect of xenobiotic metabolism which has featured prominently in the development of the discipline. The volume is testimony to the breadth and depth of research into xenobiotic metabolism and covers the chemistry and enzymology of xenobiotic metabolism, enzyme modeling and structure activity relationships, pharmacokinetics, the use of r...
The three keywords, Orthodontics, Europe and Quality represent the important issues in this book, describing the EURO-QUAL, BIOMED 1 Programme. In this Programme, individuals and representatives of institutions have been asked to contribute to the discussion on the development of a quality system for orthodontic care. The philosophy of Total Quality Management was adopted and specific emphasis was given to patient quality. When considering how the structure and quality of European orthodontic care continuously can be improved, there are certain conditions which are difficult to modify. From the start this has been realised and respected and therefore the guidelines for the quality are flexible and can be adapted to different conditions. Available knowledge has been bundled and an attempt has been made to understand the reality of orthodontic care in Europe: the product and the process.
The work presents articles on proteases and their inhibitors as mediators of biological functions. Topics addressed: cathepsin B and L; MHC and peptide interaction; procathepsin L; cysteine proteinases; selective neuronal cell death; HIV and influenza virus; tumor invasion; gingivitis; bacterial infection. Readers: professionals in the area of molecular medicine, biochemists, molecular biologists, clinical pharmacologists, pharmaceutical companies.
Much has been said about managing herpesvirus infections since the discovery of acyclovir more than 15 years ago. This book aims to bring practical advice to the key clinician who is faced with managing these infections. It addresses questions like: there are antiviral treatments for many of these infections, but who should be getting these drugs and who should not? What are the advantages, if any, of the new drugs over the old ones? Which patients should be targeted for intervention? What is the clinical reality of antiviral resistance? Where do the up and coming vaccines fit into the picture? When should therapy be discontinued or reassessed? How are patients presenting other than chorioretinitis in AIDS or pneumonitis in transplantation? The contributing clinician scientists deal with these questions and many more. Listed by Biological Abstracts/RRM, BIOSIS, volume 48, issue 8, August 1995 Covered by Current Contents, Life Sciences (ISI), volume 39, no. 2, Januari 1996, p. 12